<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xu H</submitter><funding>National Basic Research Program of China</funding><funding>National Key R&amp;amp;D Program of China</funding><funding>National Natural Science Foundation of China</funding><funding>Natural Science Foundation of Guangdong Province</funding><pagination>e41159</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6389286</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8</volume><pubmed_abstract>MicroRNA-122 (miR-122) is the most abundant microRNA in hepatocytes and a central player in liver biology and disease. Herein, we report a previously unknown role for miR-122 in hepatocyte intrinsic innate immunity. Restoration of miR-122 levels in hepatoma cells markedly enhanced the activation of interferons (IFNs) in response to a variety of viral nucleic acids or simulations, especially in response to hepatitis C virus RNA and poly (I:C). Mechanistically, miR-122 downregulated the phosphorylation (Tyr705) of STAT3, thereby removing the negative regulation of STAT3 on IFN-signaling. STAT3 represses IFN expression by inhibiting interferon regulatory factor 1 (IRF1), whereas miR-122 targets MERTK, FGFR1 and IGF1R, three receptor tyrosine kinases (RTKs) that directly promote STAT3 phosphor</pubmed_abstract><journal>eLife</journal><pubmed_title>MicroRNA-122 supports robust innate immunity in hepatocytes by targeting the RTKs/STAT3 signaling pathway.</pubmed_title><pmcid>PMC6389286</pmcid><funding_grant_id>31200593</funding_grant_id><funding_grant_id>2017YFA0504400</funding_grant_id><funding_grant_id>31471223</funding_grant_id><funding_grant_id>2011CB811300</funding_grant_id><funding_grant_id>31671349</funding_grant_id><funding_grant_id>31230042</funding_grant_id><funding_grant_id>2014A030313163</funding_grant_id><pubmed_authors>Xie SJ</pubmed_authors><pubmed_authors>Yang JH</pubmed_authors><pubmed_authors>Qu LH</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Xu SJ</pubmed_authors><pubmed_authors>Zheng MN</pubmed_authors><pubmed_authors>Zhang WQ</pubmed_authors><pubmed_authors>Xu H</pubmed_authors><pubmed_authors>Zhou H</pubmed_authors></additional><is_claimable>false</is_claimable><name>MicroRNA-122 supports robust innate immunity in hepatocytes by targeting the RTKs/STAT3 signaling pathway.</name><description>MicroRNA-122 (miR-122) is the most abundant microRNA in hepatocytes and a central player in liver biology and disease. Herein, we report a previously unknown role for miR-122 in hepatocyte intrinsic innate immunity. Restoration of miR-122 levels in hepatoma cells markedly enhanced the activation of interferons (IFNs) in response to a variety of viral nucleic acids or simulations, especially in response to hepatitis C virus RNA and poly (I:C). Mechanistically, miR-122 downregulated the phosphorylation (Tyr705) of STAT3, thereby removing the negative regulation of STAT3 on IFN-signaling. STAT3 represses IFN expression by inhibiting interferon regulatory factor 1 (IRF1), whereas miR-122 targets MERTK, FGFR1 and IGF1R, three receptor tyrosine kinases (RTKs) that directly promote STAT3 phosphor</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Feb</publication><modification>2026-05-04T08:03:04.521Z</modification><creation>2019-06-06T23:24:08Z</creation></dates><accession>S-EPMC6389286</accession><cross_references><pubmed>30735121</pubmed><doi>10.7554/eLife.41159</doi></cross_references></HashMap>